ZYJ-34c is a histone deacetylase inhibitor (HDACi) with potent orally bioavailable antitumor activities. References: Yang H, Xu W, Li Y, Lan P, Zhang J, Zhang Y, Zhang C. Superior activity of a new histone deacetylase inhibitor (ZYJ-34c) in inhibiting growth of human leukemia cells by inducing p21WAF1 expression and cell cycle arrest. Anticancer Drugs. 2014 Aug;25(7):767-77. doi: 10.1097/CAD.0000000000000101. PubMed PMID: 24686006.

纯度：≥98%

CAS：1314556-93-8